欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
EL/H/0267/002
药品名称
KYMORAL 40 mg/5 ml Oral Suspension
活性成分
simvastatin 20.0 mg/5/ml
剂型
Oral suspension
上市许可持有人
RAFARM A.E.B.E. CORINTHOU 12, 15451, N. PSYHICO
参考成员国 - 产品名称
Greece (GR)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
PL 00427/0230 - 0013
许可日期
2013/06/05
最近更新日期
2023/05/08
药物ATC编码
C10AA01 simvastatin
申请类型
TypeLevel1：
[not specified]
TypeLevel2：
[not specified]
TypeLevel3：
[not specified]
TypeLevel4：
[not specified]
TypeLevel5：
[not specified]
附件文件下载
Final Product Information
|
PI_common_SPC 20mg_track_2
Date of last change:2022/06/02
Final Product Information
|
PI_common_SPC 40mg_track_2
Date of last change:2022/06/02
Final Product Information
|
PI_common_PIL 20mg_track
Date of last change:2022/06/02
Final Product Information
|
PI_common_PIL 40mg_track
Date of last change:2022/06/02
Final SPC
|
PI_common_SPC 20mg_track
Date of last change:2022/06/02
Final SPC
|
PI_common_SPC 40mg_track
Date of last change:2022/06/02
Final PL
|
Leaflet 20mg - common1 - clean
Date of last change:2021/03/31
Final PL
|
Leaflet 40mg - common -tracked
Date of last change:2021/03/31
Final PL
|
Leaflet 20mg - common - tracked
Date of last change:2021/03/31
Final PL
|
Leaflet 40mg - common1 -clean
Date of last change:2021/03/31
PAR
|
con309572.pdf
Date of last change:2014/06/20
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase